Summary
- Current Price
- As of today, ESLA price is $0.55, up +9.50% in the most recent trading session on
- Current Price All-Time High
- ESLA price is currently -98.33% below its historical high of $33.00 set on
- Market Cap
- ESLA current market cap is $24M, down -44.37% year-over-year
- Revenue
- ESLA current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for ESLA has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Estrella Immunopharma, Inc. |
| Ticker | NASDAQ: ESLA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | estrellabio.com |
| Employees | 3 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $0.55 | ||
| Price, 1D Change | +9.50% | |
| $24M | ||
| - | ||
| - | ||
| 0.64 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.35 | ||
| EPS, 1Y Change | -46.31% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | UPTD | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.35 | ||
| EPS Estimate | -$0.75 | N/A |
| EPS Est. Change | -111.39% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| $0.55 | ||
| Price Target | $12.00 | - |
| Price Tgt. Change | +2,082.21% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$0.35 | - | |
| -$0.75 | N/A | -111.39% | |
| -$0.29 | N/A | +18.26% | |
| -$0.32 | N/A | +9.81% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -52.59% | ||
| -95.65% | ||
| -44.37% | ||
| -18.71% | ||
| 0.00% | ||
| 0.00% | ||
| -46.31% | ||
| -105.32% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $0.55 | ||
| $1.14 | ||
| $0.71 | ||
| $1.05 | ||
| $0.74 | ||
| -$0.05 | ||
| 0.64 | ||
| $0.08 | ||
| 25.20 | ||
| 102.80% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$0.35 | ||
| $0.00 | ||
| - | ||
| -$13.06M | ||
| - | ||
| -$13.06M | ||
| - | ||
| -$13.06M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 0.12 | ||
| 0.12 | ||
| - | ||
| - | ||
| -33.29 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| -3.22 | ||
| -2.46 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$10.37M | ||
| $1.38M | ||
| $3.18M | ||
| $1.68M | ||
| $13.54M | ||
| $13.54M | ||
| $0.00 | ||
| $0.00 | ||
| $554.80K |
Expenses
| Metric | Value | Date |
|---|---|---|
| $13.06M | ||
| $13.06M | ||
| $0.00 | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $800.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$1.79M | ||
| $0.00 | ||
| $2.25M | ||
| $0.00 | ||
| -$1.79M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital |
Analyst sentiment
Institutional ownership
Screeners with ESLA
FAQ
- What is the ticker symbol for Estrella Immunopharma, Inc.?
- The ticker symbol for Estrella Immunopharma, Inc. is NASDAQ:ESLA
- Does Estrella Immunopharma, Inc. pay dividends?
- No, Estrella Immunopharma, Inc. does not pay dividends
- What sector is Estrella Immunopharma, Inc. in?
- Estrella Immunopharma, Inc. is in the Healthcare sector
- What industry is Estrella Immunopharma, Inc. in?
- Estrella Immunopharma, Inc. is in the Biotechnology industry
- What country is Estrella Immunopharma, Inc. based in?
- Estrella Immunopharma, Inc. is headquartered in United States
- When did Estrella Immunopharma, Inc. go public?
- Estrella Immunopharma, Inc. initial public offering (IPO) was on September 14, 2021
- Is Estrella Immunopharma, Inc. in the S&P 500?
- No, Estrella Immunopharma, Inc. is not included in the S&P 500 index
- Is Estrella Immunopharma, Inc. in the NASDAQ 100?
- No, Estrella Immunopharma, Inc. is not included in the NASDAQ 100 index
- Is Estrella Immunopharma, Inc. in the Dow Jones?
- No, Estrella Immunopharma, Inc. is not included in the Dow Jones index
- When was Estrella Immunopharma, Inc. last earnings report?
- Estrella Immunopharma, Inc.'s most recent earnings report was on September 26, 2025
- When does Estrella Immunopharma, Inc. report earnings?
- The date for Estrella Immunopharma, Inc.'s next earnings report has not been announced yet
Data Sources & References
- ESLA Official Website www.estrellabio.com
- ESLA Profile on Yahoo Finance finance.yahoo.com/quote/ESLA
- ESLA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/esla